Proteolytic fragmentation of the murine prion protein: role of Tyr-128 and His-177

W S Perera1, N M Hooper

  • 1School of Biochemistry and Molecular Biology, University of Leeds, Leeds, UK.

FEBS Letters
|December 22, 1999
PubMed

Insights

Researchers investigated the role of specific prion protein (PrP) residues in its fragmentation. Mutations at Tyr-128 and His-177 did not affect the proteolytic cleavage, indicating these residues are not essential for PrP fragmentation.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • Prion protein (PrP) shares similarities with membrane-anchored signal peptidases.
  • Understanding PrP's proteolytic fragmentation is crucial for prion disease research.

Purpose of the Study:

  • To investigate the role of Tyrosine-128 (Tyr-128) and Histidine-177 (His-177) in the proteolytic fragmentation of murine PrP.
  • To determine if these specific residues are involved in the generation of the PrP-II fragment.

Main Methods:

  • Site-directed mutagenesis was used to create PrP mutants: PrP-Y128F and PrP-H177L.
  • Mutant PrP was expressed in human neuroblastoma SH-SY5Y cells.
  • Cell surface expression, localization in membrane domains, and proteolytic fragmentation were analyzed.

Main Results:

  • Both PrP-Y128F and PrP-H177L mutants were expressed at the cell surface as glycosyl-phosphatidylinositol-anchored proteins.
  • Mutant PrP localized to detergent-insoluble membrane domains, similar to wild-type PrP.
  • The 19 kDa proteolytic fragment, PrP-II, was detected in cells expressing either PrP mutant, indicating no significant difference from wild-type PrP fragmentation.

Conclusions:

  • Tyr-128 and His-177 are not essential for the proteolytic fragmentation of the prion protein (PrP).
  • These findings suggest other residues or mechanisms are responsible for the generation of the PrP-II fragment.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...